Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 3

1(14.3%)

7Total

N/A(6)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07089576Not ApplicableRecruiting

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

Role: lead

NCT07413926Not Yet Recruiting

Mitral Valve Repair With the Chord-X System: A Long Term Evaluation

Role: lead

NCT05174767Not ApplicableActive Not Recruiting

PERSEVERE- a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

Role: lead

NCT03669042Not ApplicableCompleted

Post-market, Prospective Evaluation of PHOTO-oxidized Bovine Pericardium in Vascular Surgery

Role: lead

NCT03035643Not ApplicableCompleted

DARTS I Feasibility Study

Role: collaborator

NCT03397251Not ApplicableCompleted

DARTS I: Feasibility, Safety, and Performance Trial

Role: collaborator

NCT04142658Phase 3Terminated

PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

Role: lead

NCT05314868Terminated

Retrospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium in Cardiac Repair or Reconstruction Surgery

Role: lead

NCT02359994Not ApplicableCompleted

Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System

Role: lead

All 9 trials loaded